+14,546.7%
NVDA vs CVS
+41.0%
+14,505.7%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -0.7% | +0.6% | +0.1% |
| 7D | -5.1% | -2.2% | -3.0% | -4.7% |
| 30D | -2.5% | -0.1% | -2.4% | -2.6% |
| 3M | +6.7% | -5.2% | +11.9% | +7.6% |
| 6M | +17.6% | +26.9% | -9.3% | +10.3% |
| YTD | +17.3% | +22.1% | -4.7% | +10.4% |
| 1Y | +23.5% | +30.8% | -7.3% | +13.8% |
| 3Y | +384.6% | +54.4% | +330.2% | +311.2% |
| 5Y | +875.4% | +33.4% | +842.1% | +770.6% |
| All | +14,546.7% | +41.0% | +14,505.7% | +11,742.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling